Oramed Pharmaceuticals Inc. (ORMP) Social Stream



Oramed Pharmaceuticals Inc. (ORMP): $4.90

-0.51 (-9.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORMP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Oramed Pharmaceuticals Inc (ORMP) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Oramed Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 3 $35 $17 $26.25 $8.65 203.47%
2021-11-10 3 $38 $17 $30 $8.65 246.82%
2022-01-18 3 $38 $30 $33.75 $8.65 290.17%
2022-03-31 4 $38 $20 $31 $8.65 258.38%

The Trend in the Analyst Price Target


ORMP's average price target has moved up $8 over the prior 29 weeks.

ORMP reports an average of 85.16% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 4 27 11 18.83 9.78 92.54%
2021-07-10 4 27 17 22.50 12.30 82.93%
2021-09-20 4 30 17 23.00 19.17 19.98%
2021-11-02 3 35 17 26.25 28.79 -8.82%
2021-12-22 4 38 30 33.75 15.38 119.44%

ORMP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


ORMP's average broker recommendation rating improved by 0 over the prior 21 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ORMP has a greater upside potential (average analyst target price relative to current price) than 544.11% of all US stocks.
  • In terms of how Oramed Pharmaceuticals Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 90.66% of that group.
  • In terms of how Oramed Pharmaceuticals Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -275.03% of that group.
  • Oramed Pharmaceuticals Inc's average analyst price target is higher than 414.06% of stocks in the small market cap category.

In the Pharmaceutical Products industry, ORIC, OPTN, and ONTX are the three stocks most similar to Oramed Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for ORMP? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.476 seconds.